Modified beam and autologous bone marrow transplantation (ABMT) for poor-prognosis Hodgkin's disease

被引:0
|
作者
Hansz, J [1 ]
Godzik, J [1 ]
Drozdowska, D [1 ]
机构
[1] Univ Med Sci, Poznan, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:118 / 118
页数:1
相关论文
共 50 条
  • [1] Autologous bone marrow transplantation (ABMT) for patients with advanced Hodgkin's disease (HD).
    Kakkas, I
    Karmiris, T
    Malekou, S
    Baltathakis, I
    Gigantes, S
    Giannakakis, A
    Pagonis, M
    Karakasis, D
    Skandalis, A
    Harhalakis, N
    Nikiforakis, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S165 - S165
  • [2] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS LYMPHOMA
    GULATI, SC
    SHANK, B
    BLACK, P
    YOPP, J
    KOZINER, B
    STRAUS, D
    FILIPPA, D
    KEMPIN, S
    CASTROMALASPINA, H
    CUNNINGHAM, I
    BERMAN, E
    COLEMAN, M
    LANGLEBEN, A
    COLVIN, OM
    FUKS, Z
    OREILLY, R
    CLARKSON, B
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1303 - 1313
  • [3] High dose chemotherapy and autologous stem cell transplantation in poor-prognosis Hodgkin's disease
    Patti, C
    Cavallaro, A
    Tringali, S
    Indovina, A
    Santoro, A
    Costa, A
    Pagano, M
    Cascio, L
    Scimè, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S265 - S265
  • [4] DOUBLE INTENSIFICATION AND ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA
    VANBESIEN, K
    MEHRA, R
    KHOURI, I
    GIRALT, S
    ANDERSSON, B
    DIMOPOULOS, T
    PRZEPIORKA, D
    GAJEWSKI, J
    RODRIGUEZ, A
    BESA, P
    DEISSEROTH, A
    CHAMPLIN, R
    BLOOD, 1993, 82 (10) : A146 - A146
  • [5] DOUBLE INTENSIFICATION AND ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA
    VANBESIEN, K
    MEHRA, R
    KHOURI, I
    GIRALT, S
    ANDERSSON, B
    WILLIAMS, P
    PRZEPIORKA, D
    GAJEWSKI, J
    RODRIGUEZ, A
    BESA, P
    DEISSEROTH, A
    CHAMPLIN, R
    BLOOD, 1994, 84 (10) : A724 - A724
  • [6] Modified dexa-BEAM and autologous stem cell grafting (SCG) in poor-prognosis patients (PTS) with Hodgkin's Disease (HD).
    Hansz, J
    Gozdzik, J
    Drozdowska, D
    Gil, L
    Kozowska-Skrzypczak, M
    Sawinski, K
    BONE MARROW TRANSPLANTATION, 2001, 27 : S270 - S270
  • [7] Autologous bone marrow transplantation in advanced Hodgkin's disease
    Annaloro, C
    Deliliers, GL
    Pozzoli, E
    DellaVolpe, A
    Oriani, A
    Ibatici, A
    Soligo, D
    Bertolli, V
    Tagliaferri, E
    LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 103 - 109
  • [8] PHASE-I TRIAL OF INTERLEUKIN-6 (IL-6) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE
    COLWILL, R
    CRUMP, M
    STEWART, AK
    DANISH, R
    SUTTON, DMC
    SCOTT, JG
    ROMEYER, F
    KEATING, A
    BLOOD, 1993, 82 (10) : A646 - A646
  • [9] A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease
    Imrie, KR
    Sheridan, B
    Colwill, R
    Crump, M
    Stewart, AK
    McCrae, J
    Danish, R
    Sutton, D
    Romeyer, F
    Keating, A
    LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 555 - 563
  • [10] High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease
    Fleury, J
    Legros, M
    Colombat, P
    Cure, H
    Travade, P
    Tortochaux, J
    Dionet, C
    Chollet, P
    Linassier, C
    Lamagnere, JP
    Blaise, D
    Viens, P
    Maraninchi, D
    Plagne, R
    LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) : 259 - 266